Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire November 07, 2025 — New preclinical data for PM577 in Wilson's Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1'26, with initial clinical data expected in 2027 — — Nominated PM647 as development candidate for Alpha-1 […]